Article

O'ZBEKISTON FARMATSEVTIKA BOZORIDA RIFAMPITSIN DORI VOSITASINING ASSORTIMENTI TAHLILI

M.N. XuddiyevaToshkent farmasevtika institutiFazliddin JalilovToshkent farmasevtika institutiM.Sh. OlimjonovaToshkent farmasevtika institutiFeruza Sodiqovna Jalilova

Zenodo (CERN European Organization for Nuclear Research)repository2023uz

ABI

Abstract

Maqolada sil kasalligida qo‘llaniladigan dori vositalarining: 2022 yil №26 O‘zbekiston Respublikasida qayd etilgan dori vositalari va tibbiy buyumlarning Davlat Reestrlari bo‘yicha va dori shakllari bo‘yicha tahlili amalga oshirilgan. Silga qarshi ishlatiladigan rifampitsin dori vositalarining farmatsevtika bozoriga kirib kelish dinamikasining ishlab chiqaruvchi davlatlar orasidagi taqsimoti va uninig assortiment tahlil natijalari keltirilgan.

Not yet translated

Topics

Education, Innovation and Language Studies Nutrition, Genetics, and Disease Medical, Sociocultural, and Biopolitical Studies

Identifiers

DOI: 10.5281/zenodo.7991422

Citations and references

Cited by 00 references

Metrics — AkademScholar